The angiotensin receptor blocker, Losartan, inhibits mammary tumor development and progression to invasive carcinoma
Coulson, Rhiannon; Liew, Seng; Connelly, Angela; Yee, Nicholas; Deb, Siddhartha; Kumar, Beena; Vargas, Ana; O'Toole, Sandra; Parslow, Adam; Poh, Ashleigh; Putoczki, Tracy; Morrow, Riley; Alorro, Mariah; Lazarus, Kyren; Yeap, Evie; Walton, Kelly; Harrison, Craig; Hannan, Natalie; George, Amee; Clyne, Colin; Ernst, Matthias; Allen, Andrew; Chand, Ashwini
Drugs that target the Renin-Angiotensin System (RAS) have recently come into focus for their potential utility as cancer treatments. The use of Angiotensin Receptor Blockers (ARBs) and Angiotensin-Converting Enzyme (ACE) Inhibitors (ACEIs) to manage hypertension in cancer patients is correlated with improved survival outcomes for renal, prostate, breast and small cell lung cancer. Previous studies demonstrate that the Angiotensin Receptor Type I (AT1R) is linked to breast cancer pathogenesis,...[Show more]
|Collections||ANU Research Publications|
|Access Rights:||Open Access|
|01_Coulson_The_angiotensin_receptor_2017.pdf||1.17 MB||Adobe PDF|
Items in Open Research are protected by copyright, with all rights reserved, unless otherwise indicated.